Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and <i>in vivo</i> evaluation

Abstract

The nanotransfersomal vesicles were significantly more efficient in nasal delivery of carvedilol with absolute bioavailability of 63.4%.